Major Events - Xizang Tianlu announced that its convertible bond "Tianlu Convertible Bond" experienced significant abnormal trading fluctuations, with a cumulative closing price increase of over 100% from July 21 to July 29, 2025, closing at 481.80 yuan per bond, representing a premium of 381.80% over the face value and a conversion premium rate of 16.60% [1] - Huqin Technology plans to acquire 6% of Jinghe Integrated's shares for 2.393 billion yuan, purchasing 120 million shares at a price of 19.88 yuan per share, marking its first stake in the company [2] - Liyuan Technology's actual controller, Shen Wanzhong, received a criminal judgment for violating information disclosure regulations, sentenced to one year in prison with a one and a half year probation, and fined 3.3 million yuan, but this will not significantly impact the company's operations [3] - Huashi Technology announced the lifting of detention measures against its actual controller and general manager, Ye Jianbiao, allowing him to resume his duties [4] - Dongfang Materials' chairman, Xu Guangbin, resigned due to personal reasons but will continue as a board member [5] - WuXi AppTec adjusted its share repurchase price limit from 90.72 yuan to 114.15 yuan per share [6] Performance Overview - Greenland Holdings reported a contract sales amount of 21.752 billion yuan in Q2 2025, a year-on-year increase of 16.93%, with a total sales area of 2.217 million square meters, up 31.03% from the previous year [7] - Lujiazui's H1 2025 net profit was 815 million yuan, a decrease of 7.87%, despite a revenue increase of 33.91% to 6.598 billion yuan [8] - Hongfa Co. achieved a net profit of 964 million yuan in H1 2025, a year-on-year increase of 14.19%, with revenue of 8.347 billion yuan, up 15.43% [9] - Nanya New Materials expects a net profit of 80 million to 95 million yuan in H1 2025, representing a year-on-year increase of 44.69% to 71.82% due to increased sales and improved product structure [9] - Sains expects a net profit decline of 57.53% to 60.13% in H1 2025, with revenue between 410 million and 440 million yuan, a year-on-year increase of 15.17% to 23.59% [9] - Baotai anticipates a net loss of 110 million to 140 million yuan in H1 2025, a reduction in losses compared to the previous year, attributed to increased sales of a specific product and reduced R&D expenses [9] Major Contracts - China CNR announced the signing of several major contracts totaling approximately 32.92 billion yuan, accounting for 13.4% of its projected revenue for 2024 [10] - Wantong Zhikong signed an exclusive authorization agreement with Shanghai Shenming Aosi Semiconductor Technology for the sales and cooperation in the field of embodied intelligence [11] - Anhui Construction won a bid for a highway concession project in Chongqing, with an estimated total investment of 3.614 billion yuan [11] Shareholding Changes - Jiahe Meikang's shareholder, Guoshou Chengda, plans to reduce its stake by up to 3% through various trading methods [12] - Lanfeng Biochemical's shareholder, Hainan Wenqin, intends to reduce its stake by up to 2.61% [12]

格隆汇7月29日丨蓝丰生化(002513.SZ)公布，持有公司股份33,589,000股，占公司总股本比例8.95%的股 东海南闻勤私募基金管理合伙企业(有限合伙)——闻勤顺为1号私募证券投资基金(简称"海南闻勤")计划 在公告发布之日起15个交易日后的3个月内通过集中竞价交易和大宗交易方式减持公司股份不超过 9,795,589股，不超过公司总股本的2.61%，其中：以集中竞价交易方式减持的股份数量不超过公司总股 本的1%，以大宗交易方式减持的股份数量不超过公司总股本的2%。 ...

蓝丰生化（002513）(002513.SZ)公告，公司股东海南闻勤私募基金管理合伙企业(有限合伙)——闻勤顺 为1号私募证券投资基金(简称"海南闻勤")计划在本公告发布之日起15个交易日后的3个月内通过集中竞 价交易和大宗交易方式减持公司股份不超过979.56万股，不超过公司总股本的2.61%。 ...

智通财经APP讯，蓝丰生化(002513.SZ)公告，公司股东海南闻勤私募基金管理合伙企业(有限合伙)—— 闻勤顺为1号私募证券投资基金(简称"海南闻勤")计划在本公告发布之日起15个交易日后的3个月内通过 集中竞价交易和大宗交易方式减持公司股份不超过979.56万股，不超过公司总股本的2.61%。 ...

人民财讯7月29日电，蓝丰生化（002513）7月29日晚间公告，公司持股8.95%的股东海南闻勤私募基金 管理合伙企业(有限合伙)——闻勤顺为1号私募证券投资基金(简称"海南闻勤")计划通过集中竞价交易和 大宗交易方式减持公司股份不超过979.56万股，不超过公司总股本的2.61%。 ...

Core Viewpoint - Hainan Wenqin intends to reduce its stake in Bluefeng Biochemical by up to 9,795,589 shares, representing 2.61% of the total share capital, within three months after the announcement [1] Group 1: Shareholder Information - Hainan Wenqin holds 33,589,000 shares in Bluefeng Biochemical, accounting for 8.95% of the total share capital [1] - The reduction will occur through centralized bidding and block trading methods [1] Group 2: Reduction Details - The maximum number of shares to be reduced via centralized bidding is limited to 1% of the total share capital [1] - The maximum number of shares to be reduced via block trading is limited to 2% of the total share capital [1]

江苏蓝丰生物化工股份有限公司 关于持股 5%以上股东减持股份预披露公告 本公司及董事会全体成员保证公告内容真实、准确和完整，不存在虚假记载、 误导性陈述或者重大遗漏。 证券代码：002513 证券简称：蓝丰生化 公告编号：2025-035 特别提示： 持有江苏蓝丰生物化工股份有限公司（以下简称"公司"或"本公司"）股 份 33,589,000 股，占本公司总股本比例 8.95%的股东海南闻勤私募基金管理合 伙企业（有限合伙）——闻勤顺为 1 号私募证券投资基金（以下简称"海南闻 勤"）计划在本公告发布之日起 15 个交易日后的 3 个月内通过集中竞价交易和 大宗交易方式减持公司股份不超过 9,795,589 股，不超过公司总股本的 2.61%， 其中：以集中竞价交易方式减持的股份数量不超过公司总股本的 1%，以大宗交 易方式减持的股份数量不超过公司总股本的 2%。 公司于近日收到持股 5%以上股东海南闻勤发送的《关于江苏蓝丰生物化工 股份有限公司股份减持计划的告知函》，现将相关事项公告如下。 一、股东的基本情况 5、减持方式：集中竞价交易或大宗交易； 6、减持价格：根据减持时的市场价格确定。 三、相关承诺及履 ...

蓝丰生化公告，持股8.95%的股东海南闻勤私募基金管理合伙企业——闻勤顺为1号私募证券投资基金 计划在本公告发布之日起15个交易日后的3个月内，通过集中竞价和大宗交易方式合计减持不超过 979.56万股，占公司总股本2.61%，其中集中竞价减持比例不超过1%，大宗交易减持比例不超过2%。 ...

证券代码：002513 证券简称：蓝丰生化 公告编号：2025-028 江苏蓝丰生物化工股份有限公司 2025 年半年度业绩预告 （二）业绩预告情况 √亏损 扭亏为盈 □同向上升 □同向下降 | 项 目 | | 本报告期 | | 上年同期 | | | --- | --- | --- | --- | --- | --- | | 归属于上市公司股东 的净利润 | 亏损：3,600 | 万元–6,800 | 万元 | 亏损：13,936.92 | 万元 | | 扣除非经常性损益后 的净利润 | 亏损：3,800 | 万元–7,000 | 万元 | 亏损：12,018.09 | 万元 | | 基本每股收益 | 亏损：0.10 | 元/股–0.18 | 元/股 | 亏损：0.39 元/股 | | 二、与会计师事务所沟通情况 本次业绩预告的相关数据未经注册会计师审计。 三、业绩变动原因说明 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、本期业绩预计情况 （一）业绩预告期间 2025 年 1 月 1 日至 2025 年 6 月 30 日。 1 特此公告。 江苏蓝丰生物 ...

证券代码：002513 证券简称：蓝丰生化 公告编号：2025-027 江苏蓝丰生物化工股份有限公司 关于投资者诉讼事项的进展公告 4、对上市公司损益产生的影响：涉诉案件相关判决涉及的赔偿金额，公司 将依据《企业会计准则》相关规定对投资者诉讼事项计提相应的负债和损益，具 体金额以审计结果为准。 江苏蓝丰生物化工股份有限公司（以下简称"公司"或"蓝丰生化"）此前 已披露关于投资者诉公司证券虚假陈述责任纠纷的诉讼事项及进展情况，并收到 江苏省高级人民法院送达的关于宋敬杰等 163 名投资者诉讼索赔案件的终审判 决。具体内容请详见公司分别于 2023 年 7 月 6 日、2024 年 6 月 5 日、2024 年 10 月 15 日和 2025 年 1 月 3 日在指定信息披露媒体披露了《关于收到〈应诉通 知书〉及〈民事裁定书〉的公告》（公告编号：2023-052）及《关于投资者诉讼 事项的进展公告》（公告编号：2024-048、2024-079、2025-002）。 近日，江苏省南京市中级人民法院（以下简称"南京中院"）针对原告 45 名 投资者与公司证券虚假陈述责任纠纷案件进行了审理，并陆续向公司送达《民事 裁 ...